Ask and you shall receive. It appears that our previous blog post was rather timely. Either that or the USDA is reading our blog. If so, don’t forget to subscribe! Enough with the shameless plugs…
» Read More
While the SAFE Banking Act remains in limbo, the hemp industry received some long overdue good news regarding banking cannabis businesses from the National Credit Union Administration (“NCUA”) with the release of interim guidelines that allow credit unions to provide banking services, including loans, to legally operating hemp businesses. » Read More
Cannabis businesses are not immune to the harsh realities of any other business. In fact, they likely deal with even more difficult challenges than more traditional businesses. For example, most businesses—if not all—should have some form of insurance and, without insurance, a business’s only remedy may be to resort to and/or be subject to the court system.» Read More
On Friday, August 9, 2019, Governor Murphy signed the New Jersey Hemp Farming Act (the “Hemp Farming Act”) into law, paving the way for hemp farming in the Garden State. Although New Jersey previously enacted an Industrial Hemp Pilot Program, that legislation was essentially mooted by the federal 2018 Farm Bill. » Read More
As discussed in our prior blog, on July 22, 2019, the Food and Drug Administration (FDA) issued a Warning Letter to Curaleaf, Inc., in connection with its marketing of certain CBD products. The following day, Curaleaf issued a statement asserting that it was committed to compliance.» Read More
Employers in New Jersey and New York City need to review their drug testing policies and employment practices considering laws recently enacted to protect employees (and applicants) who are authorized to use medical marijuana under state medical marijuana statutes.
On July 2, 2019, New Jersey joined a handful of other states affording employment protections for job applicants and employees who are legally authorized medical marijuana patients. » Read More
Parody is a common type of marketing strategy, and has notoriously been prevalent in the cannabis space, particularly with flowers and edibles. However, such use of another’s trademark or trade dress can be a recipe for litigation. The case of Mondelëz Canada Inc.» Read More
Yesterday, the FDA issued another Warning Letter in connection with the sale of CBD products, this time to well-known cannabis purveyor Curaleaf, Inc. (which operates one of our six medical dispensaries here in New Jersey and operates four dispensaries in New York). » Read More
Under the 2018 Farm Bill, CBD derived from industrial hemp falls outside the Controlled Substances Act, but CBD-infused food and beverages and dietary supplements must still comply with the Food, Drug, and Cosmetic Act and are subject to the authority of the FDA. » Read More
